The Philips CPAP Cancer & Lung Injury Litigation

On June 14, 2021, Philips announced a voluntary recall for various Philips Bi-Level Positive Airway Pressure (BiLevel PAP), Continuous Positive Airway Pressure (CPAP), and mechanical ventilator devices. The recall provides potential health risks the company identified in their devices’ polyester-based polyurethane (PE-PUR) sound abatement foam component. This component can disintegrate or outgas, causing users to inhale and/or ingest toxic and possibly carcinogenic substances. The recalled devices include those in the first generation DreamStation product family. As of July 22, 2021, the FDA issued an official Class 1 recall of numerous Philips CPAP Machines. As noted by the FDA, a class 1 recall is “the most serious type of recall. Use of these devices may cause serious injuries or death.” Devices included in this recall are listed in the section below titled “Who Is Affected by the Philips CPAP Recall?.”